Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SILO Silo Pharma, Inc. Common Stock
$3.56 -5.82% -0.22
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SILO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 4.5M
Enterprise value -1981789
Trailing PE -0.47733332316081
Forward PE -5.3217144
PEG Ratio -0.00069927811673239
Enterprise to EBITDA 0.415
Enterprise to revenue -27.486
Price to book MRQ 0.71105176
Price to sales TTM 64.71696

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 72102
EBITDA -4769916
Diluted EPS TTM -5.85
Total Cash (MRQ) 6.0M
Current ratio (MRQ) 9.653
Operating Cash Flow (TTM) -3843662

SILO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SILO News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.